In summary, while this study indicates no additional risks for adaptive immune-mediated elimination of Cas9 targeted cells that would hamper gene targeting efforts in CF, we have identified a previously unreported defect in the ability of Th1 and CD8 T cells to produce IFN-γ/TNF in response to PMA/I. This evidence concerns the gene IFNG and cystic fibrosis.